Abingworth LLP - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 73 filers reported holding IMMUNE DESIGN CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Abingworth LLP ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2018$458,000
-61.8%
352,3000.0%0.42%
-41.6%
Q3 2018$1,198,000
-26.1%
352,3000.0%0.71%
-23.1%
Q2 2018$1,621,000
+41.6%
352,3000.0%0.93%
+30.1%
Q1 2018$1,145,000
-16.7%
352,3000.0%0.71%
-28.5%
Q4 2017$1,374,000
-62.3%
352,3000.0%1.00%
-60.5%
Q3 2017$3,646,000
+7.2%
352,3000.0%2.52%
-6.7%
Q2 2017$3,400,000
+43.0%
352,3000.0%2.71%
+52.7%
Q1 2017$2,378,000
+121.2%
352,300
+78.6%
1.77%
+97.1%
Q4 2016$1,075,000
-28.0%
197,3000.0%0.90%
-37.2%
Q3 2016$1,494,000
-7.2%
197,3000.0%1.43%
-15.1%
Q2 2016$1,610,000197,3001.69%
Other shareholders
IMMUNE DESIGN CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$3,532,0000.73%
DRIEHAUS CAPITAL MANAGEMENT LLC 140,720$2,485,0000.10%
SECTORAL ASSET MANAGEMENT INC 95,000$1,678,0000.07%
Spark Investment Management LLC 18,900$329,0000.05%
Alyeska Investment Group, L.P. 46,833$827,0000.02%
FRANKLIN RESOURCES INC 802,000$14,163,0000.01%
Focused Wealth Management, Inc 450$8,0000.01%
PRICE T ROWE ASSOCIATES INC /MD/ 740,241$13,073,0000.00%
FMR LLC 900,000$15,894,0000.00%
BlackRock Fund Advisors 149,938$2,648,0000.00%
View complete list of IMMUNE DESIGN CORP shareholders